KPV / working resource
Primary source desk
Keep the original documents and the limits of their conclusions within reach.
Start with the product-specific question
KPV and alpha-MSH
A precise gut-and-skin evidence reference tied to available routes. What should I know about kpv and alpha-msh: what the fragment represents?
Open the KPV library ↗The 2008 KPV paper used human cell lines and two chemically induced mouse-colitis models, not a human randomized treatment trial.
Read the original record ↗
The original record comes first.
These are starting points for the KPV library. Read the source's exact question, product, population and date. A source can be authoritative for one claim and irrelevant to another.
Keep claims and sources together.
The 2008 KPV paper used human cell lines and two chemically induced mouse-colitis models, not a human randomized treatment trial.
Supporting record ↗It linked cell uptake to PepT1 and observed reduced inflammatory signaling and cytokine outcomes in experimental systems.
Supporting record ↗The 2017 study tested KPV in hyaluronic-acid-functionalized nanoparticles and a hydrogel, with improved experimental colitis outcomes in mice.
Supporting record ↗That engineered delivery system is distinct from ordinary KPV capsules or injections; its mouse results do not establish human clinical efficacy.
Supporting record ↗These fields stay in this page until you leave or reload. No notes are saved or transmitted. Print a copy if you want to keep your work. Educational organization tools do not replace clinical advice.